Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation

被引:3
|
作者
Sharma, Rajani [1 ]
Roy, Abhik [1 ]
Ramos, Christopher [1 ]
Rosenberg, Richard [1 ]
Garcia-Carrasquillo, Reuben [1 ]
Lebwohl, Benjamin [1 ]
机构
[1] Columbia Univ, Med Ctr, Dept Med, Div Digest & Liver Dis, 180 Ft Washington Ave,Suite 936, New York, NY 10032 USA
关键词
acidity (esophageal); acidity (intragastric); compliance; adherence; guidelines; nonvariceal bleeding; DECISION-SUPPORT-SYSTEMS; LOW-DOSE ASPIRIN; GASTROPROTECTIVE DRUGS; NSAID USERS; GI RISK; THERAPY; HOSPITALIZATION; METAANALYSIS; POPULATION; SAFETY;
D O I
10.1177/1756283X17694807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Aspirin, when used with concurrent anticoagulation, increases the risk of gastrointestinal bleeding (GIB). Therefore, multisociety guidelines recommend prophylactic proton-pump inhibitors (PPIs) for patients receiving aspirin and anticoagulation. We aimed to determine rates and predictors of adherence to these recommendations. Methods: All adult inpatients discharged from the hospital on aspirin and anticoagulation from July 2009 to June 2014 were retrospectively evaluated for PPI prescription on discharge instructions. We used univariate and multivariate logistic regression to test for predictors of PPI prescription. Results: A total of 2422 patients were discharged on aspirin and anticoagulation; the mean age was 68 years and 53.2% were male; 42.2% were prescribed a PPI at discharge. On univariate analysis, factors associated with discharge PPI prescription included increased age (47.1% versus 37.9%), white race (47.3% versus 37.1-40.2%), higher aspirin dose (55.1% versus 39.4%), being married (46.2% versus 39.4%) and preadmission PPI use (96.6% versus 23.4%). On multivariate analysis, significant predictors of discharge PPI prescription were age 60-69 years [odds ratio (OR) 1.61] and 70-79 years (OR 1.48), and preadmission PPI use (OR 120.03). Lower odds of discharge PPI prescription included Medicaid (OR 0.55) or Medicare (OR 0.71) insurance, Spanish language (OR 0.63), and lower dose aspirin (81 mg) (OR 0.40). Conclusions: A total of 42.2% of patients discharged on aspirin and anticoagulation were prescribed PPIs. Older age and preadmission PPI use were predictive of PPI prescription, while Medicaid/Medicare insurance, Spanish language, and lower dose aspirin decreased the likelihood of discharge PPI prescription. This creates an opportunity to improve primary GIB prevention through quality improvement interventions.
引用
收藏
页码:387 / 396
页数:10
相关论文
共 50 条
  • [1] Low Adherence to National Guidelines for Proton Pump Inhibitor Prescription in Patients Receiving Combination Aspirin and Anticoagulation
    Sharma, Rajani
    Roy, Abhik
    Ramos, Christopher
    Rosenberg, Richard
    Garcia-Carrasquillo, Reuben J.
    Lebwohl, Benjamin
    GASTROENTEROLOGY, 2016, 150 (04) : S635 - S636
  • [2] Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin
    Tsujimoto, Hiroyuki
    Hirata, Yuki
    Ueda, Yasuhiro
    Kinoshita, Naohiko
    Tawa, Hideki
    Tanaka, Yasuyoshi
    Koshiba, Ryoji
    Ota, Kazuhiro
    Kojima, Yuichi
    Kakimoto, Kazuki
    Takeuchi, Toshihisa
    Miyazaki, Takako
    Nakamura, Shiro
    Higuchi, Kazuhide
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (11) : 1639 - 1648
  • [3] Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin
    Hiroyuki Tsujimoto
    Yuki Hirata
    Yasuhiro Ueda
    Naohiko Kinoshita
    Hideki Tawa
    Yasuyoshi Tanaka
    Ryoji Koshiba
    Kazuhiro Ota
    Yuichi Kojima
    Kazuki Kakimoto
    Toshihisa Takeuchi
    Takako Miyazaki
    Shiro Nakamura
    Kazuhide Higuchi
    European Journal of Clinical Pharmacology, 2021, 77 : 1639 - 1648
  • [4] Adherence to guidelines in aspirin prescription in low cardiovascular risk patients
    Mattioli, A. V.
    Pennella, S.
    Migaldi, M.
    Farinetti, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 440 - 440
  • [5] Adherence to guidelines for antiulcer drug prescription in patients receiving low-dose aspirin therapy in Japan
    Iwasawa, Makiko
    Sagami, Keiko
    Yokoyama, Satoshi
    Hosomi, Kouichi
    Takada, Mitsutaka
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (04) : 197 - 206
  • [6] EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
    Hirata, Yuki
    Ueda, Yasuhiro
    Kinoshita, Naohiko
    Tanaka, Yasuyoshi
    Tawa, Hideki
    Koshiba, Ryoji
    Naka, Yutaka
    Kakimoto, Kazuki
    Takeuchi, Toshihisa
    Miyazaki, Takako
    Nakamura, Shiro
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2021, 160 (06) : S372 - S372
  • [7] Use of proton-pump inhibitor in hospitalized patients
    Gallego Galisteo, M.
    Guerra Estevez, D.
    Nunez Ortiz, C.
    Villanueva Jimenez, P.
    Villa Rubio, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 582 - 582
  • [8] PRESCRIPTION OF PROTON-PUMP INHIBITORS IN PATIENTS WHO UNDERWENT TOTAL GASTRECTOMY
    Gramage Caro, Teresa
    Alvarez Diaz, Ana
    Rodriguez Vargas, Blanca
    Perez Menendez-Conde, Covadonga
    Delgado Silveira, Eva
    Bermejo Vicedo, Teresa
    ATENCION FARMACEUTICA, 2011, 13 (03): : 172 - 175
  • [9] Proton-pump inhibitor use amongst patients with severe hypomagnesemia
    Seah, Sherry
    Tan, Yen Kheng
    Teh, Kevin
    Loh, Wann Jia
    Tan, Pei Ting
    Goh, Leng Chuan
    Malakar, Roy Debajyoti
    Aw, Tar Choon
    Lau, Chin Shern
    Dhalliwal, Trishpal
    Kui, Swee Leng
    Kam, Jia Wen
    Khoo, Joan
    Tay, Tunn Lin
    Tan, Eberta
    Au, Vanessa
    Soh, Shui Boon
    Zhang, Meifen
    King, Thomas F.
    Gani, Linsey
    Puar, Troy H.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] The Effect of a Proton-pump Inhibitor in Unexplained Chronic Cough Patients
    Yang, Joo Youn
    Lee, Ho Youn
    Kim, Nam Hee
    Kim, Youn Seup
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2006, 61 (02) : 137 - 142